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1,25-dihydroxyvitantin D3 (1,25(OHhD3) is a potent 
inhibitor of keratinocyte proliferation, as well as a 
stintulator of epiderntal terntinal differentiation. In 
the present studies, we investigated the influence of 
epiderntal growth factor (EGF) and insulin on the 
antiproliferative and differentiation activities of 
1,25(OHhD3. Our results indicate the following: (1) 
EGF caused a drantatic potentiation of the 1,25(OHh 
D3-induced inhibition of3H-thyntidine incorporation 
into keratinocytes in a dose-dependent ntanner; (2) 
insulin acted antagonistically on the EGF-dependent 
potentiation of the 1,25(OH)zD3-induced antiprolif-
erative activity; (3) transfornting growth factor-a 
potentiated 1,25(OH)zDr induced antiproliferative 
activity sintilar to EGF; (4) the EGF effect was not 
T he honnone 1,25-dihydrm.:yvitamul 0 3 (1,25(OH)2 0 3 ), an active foml ofvitamin 0 3, is well established for its role Ul regulating calcium and phosphorus transport in the bone, kidney, and intestine [1]. However, it is now recognized that the h0n110ne has other biologic 
actions in many tissues or ceLIs tha t possess the 1 ,25 (OH)203 receptor 
(VDR), including enh ancement of cellular differentiation andlor 
ulhibition of cellular proliferation in cultured fibroblasts and keratino-
cytes [2]. Incubation of cultured nomlal human and murine fibroblasts 
and keratinocytes with 1,25(OH)20 3 resulted Ul time- and dose-
dependent decreases in their proLiferation [2-4]. 1,25(OH)203 also 
stimulated tenninal differentiation in cultured keratinocytes, as evi-
denced by a dose-dependent increase in the proportion of dilferenti-
ated desquamated cells and in the comified envelope formation in 
culture [3,4]. In addition, the homlone promoted time- and dose-
dependent ulcreases in the intracellular calcium concentration [5,6] 
and in transglutaminase activity [3) . 
Epiderma l growth factor (EGF) and transforming growth fac-
tor- a (TGF-O') are potent mitogcns for a variety of cells ill IIillo as 
well as in cultures. They stimulate epidermal growth and differen-
tiation. However, it has been shown that with cultured keratino-
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dependent upon 1,25(OH)2D3 receptor ntRNA up-
regulation; and (5) rent oval of insulin front ntediunt 
supplentented with growth factors significantly po-
tentiated the 1,25(OH)zD3-induced inhibition on the 
nuntber of basal cells and the 1,25(OH)zD3-depen-
dent cornified envelope forntation. In conclusion, 
the antiproliferative activity of 1,25(OHhD3 in cul-
tured norntal hunt an keratinocytes is greatly en-
hanced by EGF or transfornting growth factor-a and 
reduced by insulm. Insulin also inhibits 1,25(OHhD3-
induced terntinal differentiation of cultured norntal 
huntan keratinocytes. Key lI1o"ds: tra"sjOf""itlg g,-oll1t1, 
jacto,'-a ltl'y",iditle itlcOf1'0ratio"lI,asal celllcor"ified enve-
lope. ] I"vest De"",a.tol 104:113-117, 1995 
cytes, EGF or TGF-O' stimulates growth only indirectly by increas-
ing migration from the edge of large colonies [7] . Because cell 
migration is essential for sustained growth ofkeratinocyte colonies, 
EGF has been included routinely in media for keratinocyte cultures. 
Another growth mctor commonly included in the keratinocytc 
growth media is ulsuLin. InsuLin is addcd at supraphysiologic 
concentrations, and it has been shown that insulin can be replaced 
in keratinocytc growth media by low concentrations of insulin-like 
growth f.1ctor type-T (IGF-I) [8] . 
T he VOR in bone cells, intestinal and uterine tissues, and 
cultu red keratinocytes has been shown to be up-regulated by 
f.1ctors such as 1,25(OHhO, itself, gLu cocorticoids, cstrogens, 
retinoic acid, and growth factors [1 ,9]. In the present studies, we 
investigated the fOIJOWUlg: (1) the influence ofEGF and TGF- O' on 
the anti proliferative activity of 1,25(OH)20 , as m easured by 
3H-thymidinc incorporation into cultured human keratinocytes, (2) 
VOR gene expression in cultured human keratinocytes in the 
presence of EGF, and (3) the effect of insulin on keratinocyte 
proljfe ration and difFerentiation. 
MATEIUALS AND METHODS 
Keratillocyte Culture Keratinocytcs were grown in culture using a 
modifi cation of the method of R heillw;.Id and Grecn [10] as described 
prcviously [3]. Briefly, keratinocytes werc obtained from neonata l foreskins 
after overnight trypsiniza tion at 4°C. Keratinocytcs werc plated and grown 
on letha lly irradiated 3T3 fibroblast feeder cells in a serum-free basal 
m edium containing 0.15 mM calcium and supplemcntcd with growth 
f.,ctors (complete mcdium). including bovine pituitary cxtract. 3 JLg/ ml ; 
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EGF, 25 ng/m l; insul in , 5 fLg/ml; and prostagland in E" 50 ng/ml. T hc bas:,) 
mcdium consisted of MCDB-153 , enri ched with various essentia l amino 
acids to final concentratio ll s as follows: L-tryptophan, 60 fLM; L-tyrosinc , 
90 fLM; L-phcnylalanine, 120 fLM; L-methioninc, 120 fLM; L-isoleucinc, 
770 fLM ; and L-histidinc, 320 fLM . To enhancc the plating efficicncy, 
cho lcra toxin (0.1 fLg/ml) and hydrocortisone (200 ng/ml) were addcd into 
the complete medium during the initial plating of the primary cu lUlre and 
thc subsequent subcultures. Cel ls were fed and maintained without cholcra 
toxi n and hydrocortisonc (thrce timcs per week). W hen the primary or the 
first-passage cu lture reached 50% to 80')1, conAuency, ceUs were detached 
from the plates with trypsin/EDTA and subcultured to obt.1ill the first- or 
second-passage cultures, respectively, as described previously [3J. 
Morphologic Studies During Keratinocyte Proliferation and Dif-
ferentiation The first-passagc cel ls werc subcultured in the complete 
m edium plus cholera tox in and hydrocortisone in to 35-mm dishcs for the 
morphologic studies. Two days after the ini tia l p lating, the m edium was 
removed and the cell s were divided into two groups: one group was fed 
with the complctc medium (+ insulin medium) and the other with comple te 
medium minus insulin ( - insulin medium) . At the second fecding period , 
triplicate plates ofken,tinocytes from each group were incubated with their 
respective fresh medium containing 1,25 (01-1)2D , (10 - ') to 10 - 7 M) or 
vehicle alonc. After threc dosings, the mcdium was removed from culturcs. 
The attached cells were then trypsinizcd for 30 min w ith 0.1 % EDT A and 
0.1 'Yo trypsin at 37°C and thcn neutralized with basa l mediulU. T he 
keratinocytes were spun down and resuspended in a known vo lume of basa l 
medium. Trip li catc aliquots were applied to a hemocytometer for counting 
the basal (small, rounded) ce ll s. T he rema ining ce ll s were spun down 'llld 
treated with 10 mM Tris-HCI (PH 7.4) w ith 1% {3-mercaptoethanol and 1% 
sodium dodecylsul fate at room temperature for 10 min . Only cells with 
corni fied cnvelopes werc prcscnt after this treatmcnt. T he corn ifi cd en ve-
lopes were counted using a hcmocytomcter. 
JH-Thymidinc Incorporation When the second-passage cells reached 
about 40% conAuency, they wcre fed with basa l medium without growth 
factors for 2 d, followed by incubating the cultures with or witho ut EGF or 
TGF-cr and with or wi thout 1,25(01-1)20 , (10 - 8 and 10- "' M), as described 
in the figure legends. Eightecn bours later, the old medium was replaced 
with 0.5 ml of fresh basa l medium containing 1 fLCi of [m ethyl-' HJthymi-
dine and incubatcd for 3 h at 37°C. ' H-T h ymidine incorporation in to DNA 
W<lS stopped by placing the 24-well plates o n icc; unincorporated ' H-
thymid ine then was removed and the cells were washed three times with 
ice-cold phosphate-buffercd saline. DNA labeled with J I-l-thymidine W;lS 
extracted by the perchl ori~ acid method, as described prev io usly [3J. 
RNA Isolation and Northcrn Blot Analysis The second-passage 
keratinocytes grown to 40% to 50% conAuency on 100-mm culture dishes 
were fed with basal medium for 2 d. Cell s thell were incubated with 0, 2.5 . 
or 25 ng/ ml of hum all recombinant EGF for 18 h at 37°C . Tota l RNA then 
was extracted from the cu lturcs according to method of C hom czynski and 
Sacchi [111 using RNAzol (Tel-Tcst B Inc .. Fri endswood, TX) . Aliquots of 
I"l..NA samplc (25 fLg) from each treatmellt group were loaded and scparated 
on 1 % agarose-formaldehyde gel w ith ethidium bromide using standard 
procedures 1l 2J. RN A bands on the ge l were transfe rred to " Zeta-probe 
membrane (Hio-Rad, Rockville Center, NY) prehybridized (4 h at 60°C), 
and the n hybrid ized (overnight at GO°C) in 50% formam ide , 5 X Den-
hardt' s, 6 X SSPE, 1 % sodium dodecylsul f"te, "nd 1 00 fLg/m l sonicated 
sa lmon sperm DNA 11 2J. T he hybridization so lu tion conta ined, in addition , 
10% dextr"n sulfate (w /v ) and the heat-denatured full-length VDR cD NA 
probes (2.0 kb). T he probes were labeled using 32p_dCTP by random 
priming extension to a specific activity of app roximate ly 10') cpml fLg [13]. 
M embranes were washed for 30 min in 1 X SSC, 0.1 % sodium dodecyl-
su lf.,te twice at 65 °C to remove excess probe. T he membranes then were 
cxposed to x-ray film (Hyperfi lm-MPO, Amersham, Arlington H eights. IL) 
at - 70°C . Thc autoradiographic images were quantified by densitometri c 
tracing. The blots were stripped and re-probed with a glyce raldehyde-3-
phosphatc dehydrogcnase (GAPD I-I) o ligon uclcotide (Oncogene Science, 
Unionda le, NY). The concentrations of vDR mRNA were no rmali zed 
according to the GAPDI-I mRNA levels. 
Materials JH_ Thymidi ll e (specific activity, 72.5 C i/ mmo l) was pur-
chased froJ1l New Engl;lI1d Nuclear (Boston . MA) . T he full-length cDNA 
probes for human vDR were obta ined from Dr. Mark Hauss ler, and human 
GAPOH from Oncogene Science. 1,25 (OH),D, was the gift of Dr. M. 
Uskokovic of Hoffil1anll -La Roche Inc. (Nutley, NJ). MCDB-153 culturc 
medium , insulin, hydrocortisone, prostaglandiJl E" and cho le ra toxin were 
obtained fj'om Sigma C hemica l Co. (St. Lou is, MO) . Recornbi nant hum an 
EGF <lnd TGF-cr was purch<l sed from Pepro Tech In c. (Rocky Hill , NJ). 
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Figure 1. Potentiation of 1,25(OH)2D,-induced inhibition of JH_ 
thymidinc incorporation into keratinocytcs by EGF, After kcratino_ 
cytes werc fed w ith basa l medium without growth f.,ctors for 2 d, ce lls were 
incubated with fresh basa l medium containing either 0 o r 25 ng/ml of EGF 
and 0,10 - 11 ', or 10- 8 M of 1 ,25(OH)2D, for 1 ~ h at 37°C. At the end of 
tI,e incubatio n period, ' H-thymidine incorporation was determined. The 
results arc presented as the percent of the contro l in the absence of 
1 ,25(01-1)20,. Each va lue is the mean ::': SEM of three separa te experi-
ments . Each expcrimen t included five to eight well s in each treatm ent 
group . *1' > 0.1; **1' < 0.005 compared to respective controls. 
Statistics R esults arc reported <IS mC<ln ::': stand<lrd e rror of the mean. and 
the Student unpa ired t test w"s used to calculate I' va lues. 
R...ESULTS 
Figure 1 d e m o nstrates that EGF at 25 ng/ml grea tly pote ntiate d 
j,25(OH)2D3-induced inhibition of 3H-thymidine in corporation 
into cultured human keratinocytes . In th e absence of EGF, 
l,25(OH)2D 3 at a concentration of 10 - '" M did not ca use ,my 
sig nifi cant reduction of 3H-thymidine incorpo ration, and on ly a 
slight inhibition (17% ± 2%) was observed with 10 - 8 M of 
1,25(OH)2D 3' On the contrary , in the presen ce of 25 n g/ml of 
EGF, 37% ± 2% and 59% ± 4% inhibitions w e re observed w ith 
10- 10 M and 10 - 8 M ofl,25(OH)2D 3' respective ly, as compare d 
to controls . The pote ntiation by EGF on the 1,25(OHhD3-induced 
inhibition of J H-thymidine in corporation was dose-dependent. 
When the EGF con centration was inc reased from 2 .5 to 12.5 to 25 
ng/ml , thymidine in corporation dec reased accordingly from 93% ± 
7% to 71% ± 3% to 65% ± 1% in the presence of 10 - '0 M 
1,25(OH)2D 3' and £i'om 86% ± 4% to 55'Yo ± l'Y., to 37'Yo ± 1% in 
the presen ce of 10- 8 M 1,25 (OH)2D3' respectively (Fig 2). EGF at 
2.5 n g/ml wa s not active in th is regard when compared to 
respective control groups (100'% ± 3% vel'sus 93% ± 7%, and 85% 
± 2% versus 86% ± 4%, fo r 10 - IU and 10 - 8 M of1,25(OH)2D J ' 
respective ly) . 
Simi larly, the antipro li ferative activity of 1,25 (OH) 2D] co uld b e 
enhan ced by TGF-a (Fig. 3) . /n t h e prese nce of 25 ng/ ml of 
TGF-a, 1 ,25(OH) 2D 3 at 10- ' u and 10 - 8 M ca used 23°/" and 38% 
inhibi tion of 3H - thymidine incorporatio n into keratinocytes, re -
spective ly . Figure 4 indicates that EGF alone at 0.25 and 2.5 n g/ml 
h ad no significan t eftec t on 3H-thymidine in corporation. Howeve r, 
at 25 ng/ml of EGF, a 20% reduction was observed. In contrast , 
under the same c ulture conditions , TGF-a caused a dose-dep e n-
d e nt inc rease in ,lH-th ymidine incorporatio n into c ulturcd kerati-
nocytes. Percentage i.n creases of 11 , 6 1 , and 243 in .1H -th ymidine 
incorporation were found in the prese n ce of 0.25, 2.5, and 25 
n g/m l ofTGF-a3, resp ectively. 
Figure 5 illu strates the eftccts of insulin a lone and in combina-
tion with EGF on the 1 ,2'5(0I-I) 2D 3- induccd inhibition of ,lH_ 
thymidinc in corporation in to c ulture d normal human k enltino-
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Figurc 2. Dosc-dcpcndcnt potcntiation of thc 1,25(OH)2D,-in-
duccd inhibition of'H-thYlnidinc incorporation illto k cratinocytcs 
by incrcasing conccntrations of EGF. Keratinocytes were incuba ted 
with 0, 2.5, 12.5, or 25 ng/ml of EGF and with 0, 10- 1(1 o r 10- 8 M 
1,25(OH)2D, for 18 h at 37°C before the ' H-thymidine incorpo ration 
period , as described in MII /crill/s IIlId /\1c/ /wds. T he results arc presented as the 
percent of the contro l in the absence ofEGI' and 1.25(01-I),D3 . Each value 
is the mean ± SEM of three separate experiments. Each experiment 
included fiv e to eight well s in each treatment group . *1' > 0. 1; **1' < 0.005 
compared to respective contro ls. 
cytes. In the absen ce of any g rowth factors, no significant ch an ges 
were observed in 3H-thymidin e incorpo ratio n . T h e addition of 
EGF (25 n g/ml) ca used a dose-depcndent inhibitio n of 3H-thymi-
dine inco rpo ration into k eratin ocytes similar to that presented in 
Fig 1. In the presen ce of 5 ILg/mJ of insu Lin, 1,25(OH)20J at both 
10 - 10 and 10- ~ M induced smaH but sta tistica lly sig nifica n t c han ges 
in JH-thymidine incorporatio n. When both EGF and insulin werc 
added to th e c ulture m edium during thc 1,25(OH)20J dosing 
p e riod, insulin completely attenuated the EGF-dependcnt, 
1,25(OH) 20 J-induced in hibitio n of JH-thymidine incorporatio n 
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Figurc 3 . Potcntiation of 1,25(OH)2Drinduccd inhibition of 3H_ 
thYlnidinc incorporation into kcratinocytcs in thc prcscn cc of 
TGF-a. Kcratinocytes were incuba ted with or without TGF-a and with or 
without 1.25 (OH),O, (10 - 10 M and 10- 8 M) for '\ 8 h at 37°C before 
' H-thymidine incorpor:ltion was carri ed o ut, as described in MtlIe"; lI /s II l1d 
M e/h ods. T he resu lts arc presented as the percent of the control. Each va lue 
is the mean ± SEM of five to e ight dete rminations from a represen~ati ve 
experiment. *p > 0. '1 , ** 1' < 0.005 comp~red to respective conLTo ls. 
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Figurc 4. Stimulation of .lH-thytnidinc incorporation into kcratino-
cytcs in the prcsencc ofincrcasi.ng conccntrations ofTGF-a, but not 
EGF. During the 18-h period before ' H-thymidinc incorporation, keratino-
cytes were incubated with increasing concentrations ofTGI'-a or EGF (0, 0.25, 
2.5, or 25 ng/ml) in the absence ofl.25(OH),DJ. The results ~re presented ~s 
the percent of the control in the ~bsence ofTGF-a or EGF. Each value is the 
mean ± SEM of five to eight detcnninations 6'0111 a representative experiment. 
' 1' > 0.1; *'1' < 0.005 compared to respective controls. 
into cultured human keratinoc),tes. The antagolUStlc effect of 
insulin o n the 1,25(OHh03-induced inhibi tion of 3H-thymidine 
incorp o ration in th e presence of EGF was supported by counting 
the numbe r of basal ce l1 s after 1 week of e xposure to 1,25(OH>z03 
(Fig 6). W h e n ke ra ti n ocytes wcre grown in a complete m edium 
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Figurc 5. Antagonistic action of insulin on the EGF-depcndcnt 
potcntiation of thc 1,25(OH)2D,-induccd inhibition of .lH_thynti_ 
dinc incorporation into kcratinocytcs. After keratinocytes were grown 
in basa l mcdiulll witho ut growth f:,ctors for 2 d, cultures were divided into 
four groups . Group I (the con trol group) w~s incubated in the basa l mediu111 
without any growth f.,ctorS; group 2 was supplemented with EGI' (25 
ng/ml); group 3 was supplemented with insulin (5 flog/ ml); group 4 was 
incubated with both EGF (25 ng/ ml) and insulin (5 flog/ ml) in basal 
medium . Each group was divided further into three subgroups and treated 
with 0, 10- 10 M, or lO - " M 1 ,25(01-l),D, at the same time the cell s were 
treated with growth f.1ctor(s), before JH-thymidine incorporation. T he 
resul ts llre presented as the percent of the control in the absence of 
1,25(O H)2DJ. Each va lue is the mean :!: SEM of five to eight detennina-
tions from a representative experiment. ' 1' > 0. 1; " 1' < 0.05; "'1' < 0.005 
comp~red to respective controls. 
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Figure 6 . Attenuation of the 1,25(OH),D.l-induced inhibition of 
keratinocyte basal cell proliferation by insulin. T he second-passage 
keratinocytes were plated on 35-mm dishes in the same medium as 
described in Materials nllfl MetllOds for the primary cultures, and were used 
for the morphologic studies. Two days after the initial plating, dishes were 
divided into two groups and fed with ( + insulin group) or without (- insulin 
gro up) insulin for the rest of the experiment. At the next feeding, groups of 
triplicate di shes from e ither the - insulin or + insulin group were incubated 
with fresh medium containing 0,10 - 9 , 10- ", or 10- 7 M 1 ,25(OH)2D .l ' After 
"[ week of dosing with 1,25(OH),DJ (three dosings), cells were counted as 
described iJl Matelials mId M ethods. E.,ch value is the mean :t SEM of three 
detenllinations from a representative experiment. *p > 0.1; " p < 0.05; "'p 
< 0.0005 compared to respective controls. 
containing MCDB-153 with growth factors including bovine pitu-
itary extract, EGF, insulin, and prostaglandin EI> 1,25(OH)2D3 at 
e ithe r 10 - 9 or 10 - 8 M did not cause any inhibition in basal cell 
number. Only when the concentration of 1,25(OH)2D 3 reached 
10 - 7 M was a small but significant inhibition (17%) observed in 
basal cell number. However, the antiproliferative effect of 
l,25(OH)2D3 was greatly enhanced wh en insulin was removed 
from the culture medium: 15%, 26%, and 75'Yo inhibitions of basal 
cell proliferation were 'observed with 10- 9 , 10 - 8 , and 10 - 7 M of 
1,25(OHh D 3' respectively. In addition, removal of insulin from 
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Figure 7. Attenuation of the 1,25(OH)2D , -iuduced cornified-enve-
lope formation by insulin. The second-passage keratiJ,ocytes were treated 
with or without insulin and with or without l,25(OH),D" as described in the 
legend of Fig 6. C ornified envelopes were prepared from cultures as described 
in Materials alld Methods. Each value is the mean' :t SEM of three detenninations 
from a representative experiment. *p > 0.1; '*p < 0.05 compared to respective 
controls. 
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Figure 8. Northern analysis of VDR mRNA prepared from cul-
tured human keratinocytes treated with or without EGF. Keratino-
cytes w ere grown and prepared as described in lvlaterials alld M et/",ds. The 
second-passage keratinocytcs , grown in 100-mm dishes and in basa l me-
dium (without growth factor) for 2 d , were treated with 0, 2 .5 , or 25 ng/ ml 
EG F for 18 h before the ce ll s were harvested for KNA isolation and 
Northern analysis. Concentrations of VDR. mRNA were normalized ac-
cording to GAPDH m~A levels. Lalle I, con trol; lalle 2, 2.5 ng/ml EGF; 
lalle 3, 25 ng/ml EGF. 
the culture medium ca used a dose-dependent increase in cornified-
envelope formation in cultured keratinocytes (Fig 7) . 
Finally, we investigated the possibility that EGF might up-
regu late VDR gene expression and, therefore, increase 1,25(OH)2D3-
induced inhibition of 3H-thymidine incorporation into keratinocytes. 
The results of the Northern blot analysis are illustrated in Fig 8. 
Quantitative analyses of the autoradiographic bands using densitomet-
ric tracing indicated that EGF at either 2.5 or 25 ng/mJ did not increase 
VDR mRNA levels over control (Inlles 2, 3 versus Inlle 1), after 
nomlalization of the intensity of VDR mRNA bands to the same 
GAPDH mRNA level. 
DISCUSSION 
Previously, l,25(OH)2D 3 was reported to modulate EGF receptors 
in cultured hum an keratinocytes by shifting a portion of the 
receptors from high affinity to low affinity without affecting the 
total number ofEGF receptors [14]. On the other hand, Krishnan 
and Feldman [15] reported that EGF up-regulated VDR gene 
expression and therefore increased the VDR level ill both NIH-
3T3 mouse fibroblast cells and MCF-7 human breast cancer cells. 
In the present study, we demonstnlted that EGF greatly enhanced 
the antiproliferative activity of 1,25(OH)2D 3 in cultured human 
keratinocytes (Figs 1 and 2) without increasing the VDR mIlNA 
level (Fig 8). T hese results suggest that the effect of EGF on the 
potentiation of 1,25(OH)2D 3-induced inhibition of 3H - thymidille 
incorporation was not dependent upon VDR mRNA expression or 
on the stabilization of its transcripts. It is possible that VDR may be 
phosphorylated at tyrosine residues catalyzed by EGF-specific 
protein tyrosine kinase, which in turn may result ill the formation of 
a more stable or a more active VDR, thereby contributing to the 
increased antiproliferative activity of 1,25(OH)2D 3 in keratinocytes 
ill the presence of EGF. Phosphorylation of VDR has been sug-
gested as a primary event in 1,25(OH)2D 3 actions [16]. 
Although EGF has been shown to enhance 3H-thymidine incorpo-
ration in NIH-3T3 and MCF-7 cells [1 5], the growth factor did not 
stimulate 3H-thymidine incorporation illto DNA of cultured human 
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keratinocytes (Fig 4). In fuct, EGF at 25 ng/ml, a concentra tion 
commonJy used in cell cultures, slightly decreased the incorporation of 
3H-thymidine into DNA. T lus finding is consistent wi th the view that 
EGF stimu.lates cell grOWtll in an indirect fasluon by increasing 
migration away from the edge oflarge keratinocyte colOlues [7 ,22]. A 
sinUlar finding was reported by van Leeuwen et al [17] , specifically that 
EGF had no effect on DNA syntllesis in UMR 106 osteoblastic cells. In 
contrast, TGF-a greatly enhan ced )H -thymidine incorporation in a 
dose-dependent manner in keratinocytes (Fig 4). It is difficult to 
lUlderstand why TGF-a and EGF, w hich share the same EGF receptor, 
have such a different effect on DNA synthesis, yet bo tll stimulate 
1,25(OH)2D 3-induced inlubition oeH-tilynudine incorporation . T he 
differential effect between these growtll fac to rs also was observed by 
BalTando and Green [7], who found that TGF-a w as more active than 
EGF in a keratinocyte cell-migration assay. 
T he ro le of insulin in cell culture is less w ell det1 l~ed . Severa l 
groups of in vestigators reported that the re was n o ben efi t, w hereas 
others found enhancement ofkera tinocyte migration [18] and up to 
30% growth stimul ation in cultured keratinocytes [19]. It has been 
reported that IGF-I and IGF-II w ere able to substitute fo r insulin at 
a much low er concentration (50-200 ng/ml) than insulin (5 
fLg / ml) [8,20,21]. H ow ever, the presence ofEGF was shown to be 
necessary fo r either IG F-I or high- dose in sulin to cause significant 
ke ratinocyte growth. It was demonstrated that IGF-I or lugh-dose 
insulin increased the number of EGF-binding sites on keratinocytes 
without altering EGF-binding aflini ty [21 ]. In addition , the stimu-
lato ry effect of IGF-I and IGF-I1 on SCL-1 cell growth was 
completely blocked by a specific IGF-I recepto r antibody, alpha 
IR- 3, suggesting that the effect was m ediated thro ugh the IGF-I 
receptor [22] . In contrast, the lugh- dose insulin action was inhibited 
only par tially by the antibody, indicating that insulin could act 
through bo th insulin and IGF-I receptors. SCL-1 is a skin-derived 
squamous cell carcinoma cell line. It is important to know whether 
the antibody will inhibit the effects of IGFs and insulin in cultured 
kera tinocytes . W e found a 24% :'::: 5% decrease in the n umber of 
basal cells in cultures m aintained in MC DB-153 complete m edium 
that contained all four growth fac tors, including insulin (5 fLg/ ml) , 
as compared to cells grown in the same medium with growth 
fac tors but no insulin (Fig 6) . In addition, insulin at pharmacologic 
concentration had negative effects on the 1,25 (O H)2D 3-induced 
antiprolife rative activity (Figs 5 , 6) and on cornified-envelope 
form ation induced by 1 ,25(O H) 2D 3 (Fig 7) . Whether th e observed 
insulin effects on 1,25 (O H h D 3-induced antiprolife rative activi ty 
and on comified-envelope fo rmation can be repro duced with low 
concentrations ofIGF-I or IGF-II is not known. In any event, it would 
be of great importan ce if the EGF and insulin effects observed in ;1/. II ;t I'O 
cell cul ture conditions have any therapeutic application in the treat-
ment of hypeqJroliferative skin diseases such as psoriasis. 
In summary, EGF, TGF- a , and insulin pl ay important roles in 
regulating the antiprolife rative activi ty of 1 ,25 (O H) 2D 3 in cultured 
nOn1lal hmllan keratinocytes . T he antiprolife rative activi ty of 1,25-
(OHhD ) , as analyzed by the inJubition of 3 H - th)'1ludine incorporation 
and basal cell number, is grea tly increased in tile presence of EGF and 
reduced by tile presence of insulin in culture medium. Insulin also 
prevents cornified-envelope fonllation induced by 1,25 (O H hD3 in 
cultm'ed n ormal human keratinocytes. 
T ltis work ,,,as sIIpporled ill ptll1 by grallls R O J-ilR 36963, ROJ-DK 43 690, m,d 
MO IRR00533 fro ", lit e N alioll a/ JII sl.illlfes ()J H en/I/1. W e ",,, ,,/d like It) Iil a" k 
Belillda C lr ert, E lt,illc C lrell, nlld Da ll id J ack.HJI/ f() r preJi arilig lire graJi lrics. 
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